Elucid is a Boston-based medical technology company using histology-validated software to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid's CTA analysis equips physicians with critical information designed to enable precision medicine. Elucid is the first non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall. Elucid's unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs.
Looking for a particular Elucid employee's phone or email?
Elucid Questions
The Elucid annual revenue was $6.1 million in 2026.
Andrew Miller is the CTO and SVP Engineering of Elucid.
18 people are employed at Elucid.
Elucid is based in Boston, Massachusetts.
The NAICS codes for Elucid are [51, 511, 513, 5112].
The SIC codes for Elucid are [737, 73].
Top Elucid Employees
-
Andrew Miller
CTO and SVP Engineering at Elucid
Boston, MA, US11 -
Windi Hary
Head of Quality and Regulatory at Elucid
Los Gatos, CA, US35+ -
2
-
Greg Boverman
Principal Image Processing Engineer at Elucid
Boston, MA, US13 -
11
Related Companies
